Last reviewed · How we verify
LTC 5 minutes
At a glance
| Generic name | LTC 5 minutes |
|---|---|
| Also known as | Pliaglis cream, Lidocaine 70 mg/g + tetracaine 70 mg/g cream |
| Sponsor | Netherlands Institute for Pigment Disorders |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- R21: An Easy-to-use, iNtelligent, Affordable LinEr (ENABLE) System for Socket Fit Assessment (NA)
- SOcial coNNEction in Long-Term Care Home Residents
- Use of Walkers in Infancy and Musculoskeletal System (NA)
- Fractional Laser Assisted Delivery of Anesthetics IIIb (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- LTC 5 minutes CI brief — competitive landscape report
- LTC 5 minutes updates RSS · CI watch RSS
- Netherlands Institute for Pigment Disorders portfolio CI